RE:Waiting leads to worry, facts can help....Companies that have something to sell and are negotiating with multiple parties who are interested in buying what they have to sell (i.e. the company) don't telegraph their intentions until the multi-party negotiations are completed and the deal is closed !
The same applies to the buyers, such as the Big Pharma companies who are not inclined to telegraph their overall intentions either.
Those seeking to detract on the various message baords have no direct part in the above process, and are more interested in getting the best price on the sellers stock ....
.... especially on a company that has a putative/speculative/potential M&A acquisition valuation of approximatley US$9-10 Billion for ONCY, as a bolt-on acquistion, which is a valuation that comfortably falls within Big Pharma's M&A "sweet spot" range of US$5-15 Billion.